Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma

NEXT STORY
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology
PREV STORY
The U.S. esoteric testing market size is expected to grow at a CAGR of around 7% during 2020-2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema

Intended for Global Audience Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for ...

author_avatar
NASDAQ Market News

CrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes

SANTA CLARA, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

ZIOPHARM Oncology to Present Updated Clinical Results of Gene Therapy Candidate Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting

BOSTON, April 20, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News